JP2019518034A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518034A5
JP2019518034A5 JP2018564968A JP2018564968A JP2019518034A5 JP 2019518034 A5 JP2019518034 A5 JP 2019518034A5 JP 2018564968 A JP2018564968 A JP 2018564968A JP 2018564968 A JP2018564968 A JP 2018564968A JP 2019518034 A5 JP2019518034 A5 JP 2019518034A5
Authority
JP
Japan
Prior art keywords
optic
alkyl
medicament according
day
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018564968A
Other languages
English (en)
Japanese (ja)
Other versions
JP6872805B2 (ja
JP2019518034A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/087341 external-priority patent/WO2017211274A1/en
Publication of JP2019518034A publication Critical patent/JP2019518034A/ja
Publication of JP2019518034A5 publication Critical patent/JP2019518034A5/ja
Priority to JP2021067485A priority Critical patent/JP2021113204A/ja
Application granted granted Critical
Publication of JP6872805B2 publication Critical patent/JP6872805B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018564968A 2016-06-08 2017-06-06 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用 Active JP6872805B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021067485A JP2021113204A (ja) 2016-06-08 2021-04-13 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662347103P 2016-06-08 2016-06-08
US62/347,103 2016-06-08
PCT/CN2017/087341 WO2017211274A1 (en) 2016-06-08 2017-06-06 Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021067485A Division JP2021113204A (ja) 2016-06-08 2021-04-13 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用

Publications (3)

Publication Number Publication Date
JP2019518034A JP2019518034A (ja) 2019-06-27
JP2019518034A5 true JP2019518034A5 (https=) 2020-01-16
JP6872805B2 JP6872805B2 (ja) 2021-05-19

Family

ID=60577583

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018564968A Active JP6872805B2 (ja) 2016-06-08 2017-06-06 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用
JP2021067485A Pending JP2021113204A (ja) 2016-06-08 2021-04-13 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021067485A Pending JP2021113204A (ja) 2016-06-08 2021-04-13 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用

Country Status (12)

Country Link
US (2) US11406616B2 (https=)
EP (1) EP3468551A4 (https=)
JP (2) JP6872805B2 (https=)
KR (1) KR20190017873A (https=)
CN (2) CN117298092A (https=)
AU (1) AU2017277005B2 (https=)
CL (1) CL2018003537A1 (https=)
MX (1) MX2018015188A (https=)
NZ (1) NZ749389A (https=)
SG (1) SG11201810580PA (https=)
TW (1) TWI749016B (https=)
WO (1) WO2017211274A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004023A2 (pt) * 2017-09-12 2020-09-08 Sunregen Healthcare Ag uso de um composto e composição farmacêutica ou suplemento nutricional
CN111773351A (zh) * 2019-09-20 2020-10-16 厦门医学院 瓶尔小草及姜黄组合物在制备降血糖及降血压的药物组合物中的应用
CN111773274A (zh) * 2019-09-20 2020-10-16 厦门医学院 瓶尔小草及车前子组合物在制备降血糖及降血压的药物组合物中的应用
JP7685134B2 (ja) * 2019-11-27 2025-05-29 リファインホールディングス株式会社 インスリン分泌促進剤並びにこれを用いた血糖値改善剤、糖尿病改善剤及び食品
WO2022263624A1 (en) * 2021-06-18 2022-12-22 Sunregen Healthcare Ag Novel compounds for the treatment and prevention of neurological complications of viral infections
JP2023061448A (ja) * 2021-10-20 2023-05-02 リファインホールディングス株式会社 小胞体ストレス抑制剤、神経変性疾患予防改善剤および認知症の予防・進行防止・改善剤、並びに食品
US20260060952A1 (en) * 2022-10-02 2026-03-05 Refine Holdings Co., Ltd. Prophylactic, Progression Inhibitor, Ameliorant for Visual Field Defect Disorders, Light-Induced Ocular Tissue Disorders and Related Disorders, and Food Product

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS558351A (en) 1978-07-05 1980-01-21 Hitachi Ltd Press machine
DE3032300A1 (de) 1980-08-27 1982-04-01 Alfred Ing. Wien Lohninger Mittel zur parenteralen ernaehrung
JPS5919775U (ja) 1982-07-26 1984-02-06 ワイケイケイ株式会社 カ−テンウオ−ルの断熱窓
CA1244772A (en) 1983-06-21 1988-11-15 Kuniaki Adachi Cell-stimulating composition
JPH02247125A (ja) 1989-03-17 1990-10-02 Koken Kk 悪性腫瘍細胞増殖抑制剤
JP3558351B2 (ja) 1992-12-07 2004-08-25 邦郎 辻 免疫抑制剤
DE19821003A1 (de) * 1998-05-11 1999-11-18 Dresden Arzneimittel Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US20020006959A1 (en) 2000-05-01 2002-01-17 Henderson Samuel T. Use of medium chain triglycerides for the treatment and prevention of Alzheimer's Disease and other diseases resulting from reduced Neuronal Metabolism
AU2001264079A1 (en) 2000-06-14 2001-12-24 William Leslie Porter Lipids for modulating immune response
IL142535A0 (en) 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
JP5026655B2 (ja) 2001-04-18 2012-09-12 プロメティック、バイオサイエンシーズ、インコーポレーテッド 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体
CN1764446A (zh) * 2003-03-13 2006-04-26 康福玛医药公司 含有长链和中链甘油三酯的药物制剂
US8399515B2 (en) 2003-05-20 2013-03-19 Baylor Research Institute Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements
FI20060154A7 (fi) 2003-08-18 2006-05-11 Btg Int Ltd Neurogeneratiivisten tilojen hoito
JP4334956B2 (ja) 2003-09-18 2009-09-30 株式会社ノエビア 細胞賦活剤、美白剤、及び抗酸化剤
CN101137369A (zh) * 2005-02-09 2008-03-05 马库赛特公司 用于眼治疗的制剂
CA2700431A1 (en) 2006-09-26 2008-04-03 Baylor Research Institute Use of odd-chain fatty acids in the modulation of cellular catabolism
EP1929995A1 (en) 2006-12-04 2008-06-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Anaplerotic therapy of Huntington disease and other polyglutamine diseases
KR100829729B1 (ko) 2007-01-29 2008-05-15 한불화장품주식회사 병이소초 추출물을 주요 활성성분으로 함유하는 피부외용제 조성물
PT2299998T (pt) 2007-11-02 2018-04-02 Prometic Pharma Smt Ltd Acidos gordos e glicerídeos de cadeia média como agentes nefroprotetores
DE102008046227A1 (de) * 2008-06-10 2009-12-17 Ludwig-Maximilians-Universität München Hochdurchsatzmethode zur Analyse der Fettsäurezusammensetzung in Plasmaphosphoglyceriden
DE102008057867A1 (de) * 2008-11-18 2010-05-20 B. Braun Melsungen Ag Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten
CN101879156B (zh) 2009-05-07 2013-01-30 上海医药工业研究院 一种药物组合物及其应用
KR20120129898A (ko) 2009-12-30 2012-11-28 베일러 리서치 인스티튜트 알츠하이머 질환 및 노화 뇌를 위한 보충대사 치료요법
MX337605B (es) * 2010-01-08 2016-03-10 Catabasis Pharmaceuticals Inc Derivados de fumarato de acido graso y sus usos.
CN102883733B (zh) * 2010-02-10 2014-08-13 奥力榨油化株式会社 Age生成抑制剂
US20110301238A1 (en) * 2010-06-02 2011-12-08 Borges Karin Seizure related disorders and therapeutic methods thereof
JP2013528648A (ja) 2010-06-14 2013-07-11 ベイラー リサーチ インスティテュート 成人ポリグルコサン小体病（ａｐｂｄ）を処置するためのトリヘプタノイン食
EP2407155B1 (en) * 2010-07-15 2012-12-26 Hybrigenics S.A. Formulations of inecalcitol
CN103945840A (zh) 2011-08-26 2014-07-23 国立大学法人大阪大学 糖尿病性心血管并发症的预防/治疗剂
CN102526643B (zh) * 2012-03-22 2013-09-11 常熟市虞山绿茶有限公司 一种治疗口腔溃疡的中草药含片
CA2894456C (en) 2012-12-13 2022-06-28 Baylor Research Institute Triheptanoin for the treatment of glucose transporter 1 deficiency
CN117502539A (zh) * 2013-08-02 2024-02-06 施韦特-莫迪国际公司 包含经重构植物材料的可食用产品
ES2774321T3 (es) 2013-11-14 2020-07-20 Univ Queensland Trastornos neurodegenerativos y métodos de tratamiento y diagnóstico de los mismos
CN103641713B (zh) 2013-11-15 2015-10-21 浙江大学 甘油单酯衍生物的制备方法及应用
WO2015110977A1 (en) 2014-01-22 2015-07-30 Rolexi Marketing (Pty) Ltd Fatty acid composition and medicinal use thereof
CN104286296A (zh) * 2014-09-25 2015-01-21 王美华 一种凉茶
JP6406978B2 (ja) 2014-11-04 2018-10-17 株式会社シー・アクト 脂肪酸混合物
CN105267501A (zh) * 2015-11-04 2016-01-27 夏茂森 一种治疗毒蛇咬伤的中药组合物
CN105381182A (zh) 2015-11-20 2016-03-09 冯天寿 一种治疗慢性荨麻疹的中药及其应用
EP3383382A1 (en) 2015-12-04 2018-10-10 Nestec S.A. Method for improving cognition

Similar Documents

Publication Publication Date Title
JP2019518034A5 (https=)
JP2015532295A5 (https=)
JP2019504100A5 (https=)
JP2015518001A5 (https=)
JP2016538257A5 (https=)
JP2014528485A5 (https=)
JP2022506111A5 (https=)
JP2017526677A5 (https=)
JP2012513416A5 (https=)
JP2019535723A5 (https=)
NZ749389A (en) Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
JP2013500314A5 (https=)
JP2016513130A5 (https=)
JP2016506916A5 (https=)
JP2019500387A5 (https=)
WO2009082819A8 (en) Novel lupane derivatives
JP2019507764A5 (https=)
JP2011529964A5 (https=)
JP2018538273A5 (https=)
JP2021503449A5 (https=)
JP2016531871A5 (https=)
RU2016151420A (ru) Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий
JP2017505785A5 (https=)
MX2021012491A (es) Agentes antiproliferativos para el tratamiento de la hipertensión arterial pulmonar.
JP2019519593A5 (https=)